REGULATORY INTELLIGENCE·Warning Letter
FDA Class I Recall: Torrent Pharmaceuticals' Anagrelide Capsules Fail Dissolution, Triggering Supply Chain Review
Torrent Pharmaceuticals Limited's Class I recall of Anagrelide Capsules due to failed dissolution specifications underscores critical supply chain and regulatory risks. This event, impacting 2,496 bottles nationwide, necessitates immediate review of sourcing strategies for essential medicines. Procurement and regulatory leaders must assess supplier quality systems and diversify supply to mitigate future disruptions and ensure patient safety.
90-Day Activity